BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6498321)

  • 1. [Lipid peroxidation in children with Duchenne's hereditary myopathy].
    Grinio LP; Orlov ON; Prilipko LL; Kagan VE
    Biull Eksp Biol Med; 1984 Oct; 98(10):423-5. PubMed ID: 6498321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Membrane pathology in human myodystrophy].
    Badalian LO; Grinio LP; Islamova IB; Belousova LV; Fedosov SN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1631-3. PubMed ID: 4082830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytoplasmic and mitochondrial aspartate aminotransferase in Duchenne's progressive muscular dystrophy.
    Janik P; Nowak I; Niebrój-Dobosz I
    Mater Med Pol; 1994; 26(3):101-4. PubMed ID: 7603078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accumulation of gaseous products of lipid peroxidation in the expired air of human subjects during hyperbaric oxygenation].
    Prilipko LL; Orlov ON; Kagan VE; Savov VM; Saltanov AI
    Biull Eksp Biol Med; 1983 Oct; 96(10):24-6. PubMed ID: 6626724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Content of hypophysiotropic, adrenotropic and thyrotropic hormones in the blood in Duchenne's progressive muscular dystrophy].
    Badalian LO; Grinio LP; Sel'verova NB; Gerasimova OI; Temin PA
    Vopr Med Khim; 1982; 28(4):30-4. PubMed ID: 7113051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma lipids of patients with Duchenne's muscular dystrophy at different stages of the disease].
    Temin PA; Islamova IB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(11):1632-6. PubMed ID: 6675360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duchenne's muscular dystrophy: the electrocardiogram in female relatives.
    Mann O; DeLeon AC; Perloff JK; Simanis J; Horrigan FD
    Am J Med Sci; 1968 Jun; 255():376-81. PubMed ID: 5654956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myocardial lesions in several forms of progressive muscular atrophy].
    Popov'ian MD; Dubinskaia EE; Proshina OV; Tul'skaia MP; Loginova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):330-5. PubMed ID: 6720172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alcoholic cirrhosis on ethane and pentane levels in breath.
    Moscarella S; Caramelli L; Mannaioni PF; Gentilini P
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):529-33. PubMed ID: 6712818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum enzyme lowering and other effects of diethylstilbestrol (DIES) in Duchenne's muscular dystrophy (DMD).
    Cohen L; Morgan J; Schulman S; Lawrence A
    J Lab Clin Med; 1971 Nov; 78(5):797-8. PubMed ID: 5128833
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemiluminescence of blood plasma and functional status of the erythrocytes of patients with various hereditary neuromuscular diseases].
    Sitnikov VF; Khrennikov VIu; Teselkin IuO
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):376-81. PubMed ID: 3577527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systolic time interval characteristics in children with Duchenne's progressive muscular dystrophy.
    Sanyal SK; Tierney RC; Rao PS; Pitner SE; George SL; Givins DR
    Pediatrics; 1982 Dec; 70(6):958-64. PubMed ID: 7145553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
    Radu H; Keresztes L; Stenzel K
    Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-genealogic analysis of the malignancy of Duchenne's progressive muscular dystrophy].
    Kavtaradze NP; Mindadze BA; Natriashvili GD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):26-8. PubMed ID: 7180299
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
    McCormick D; Allen IV
    Ulster Med J; 1976; 45(1):79-83. PubMed ID: 936362
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive muscle disease in a young woman with family history of Duchenne's muscular dystrophy.
    Olson BJ; Fenichel GM
    Arch Neurol; 1982 Jun; 39(6):378-80. PubMed ID: 7092617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modifications of serum creatine phosphokinase activity under the influence of lithium gluconate in Duchenne's myopathy].
    Chazot G; Fournis Y; Robert JM; Aimard G; Devic M
    Lyon Med; 1972 Nov; 228(17):421-5. PubMed ID: 4658522
    [No Abstract]   [Full Text] [Related]  

  • 20. Sudden cardiac arrest during adenotonsillectomy in a patient with subclinical Duchenne's muscular dystrophy.
    Benton NC; Wolgat RA
    Ear Nose Throat J; 1993 Feb; 72(2):130-1. PubMed ID: 8482252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.